• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性透析患者的铁过载与骨病

Iron overload and bone disease in chronic dialysis patients.

作者信息

Van de Vyver F L, Visser W J, D'Haese P C, De Broe M E

机构信息

Department of Nephrology-Hypertension, University of Antwerp (UIA), Belgium.

出版信息

Nephrol Dial Transplant. 1990;5(9):781-7. doi: 10.1093/ndt/5.9.781.

DOI:10.1093/ndt/5.9.781
PMID:2129351
Abstract

Bone pathology was studied in 27 patients showing either iron or aluminium accumulation in bone. These patients belonged to a group of 120 unselected chronic haemodialysis patients in whom transiliac bone biopsies had been obtained. Group A consisted of 12 patients with bone iron deposits (positive Perls' staining at the calcified bone boundary, CBB) and only minimal aluminium accumulation (bone aluminium below 20 micrograms/g wet weight). Group B included 15 patients with pronounced aluminium accumulation (positive aluminium staining at the CBB and bone aluminium of 20 micrograms/g wet weight or more) and without significant bone iron deposition (negative Perls' staining at the CBB). Bone diseases were classified as early hyperparathyroidism, osteitis fibrosa, mixed disease, osteomalacia, adynamic bone disease or other bone condition using osteoid volume, relative osteoblastic activity (ROBA%), and the presence of fibrosis, as criteria. In group A, 5 of 12 patients showed adynamic bone disease, a fairly uncommon condition in the general population of non-parathyroidectomised dialysis patients. In fact, in a control group of 80 patients without iron and without aluminium overload, only five patients showed adynamic bone disease. In group B, 8 of 15 patients showed osteomalacia, and 2 of 15 presented with mixed disease, which is in agreement with the established relationship between bone aluminium accumulation and the occurrence of defective bone mineralisation. It is concluded that iron overload in dialysis patients is associated with an increased frequency of adynamic bone disease.

摘要

对27例骨中显示有铁或铝蓄积的患者进行了骨病理学研究。这些患者来自一组120例未经挑选的慢性血液透析患者,均已获取了经髂骨骨活检样本。A组由12例有骨铁沉积(钙化骨边界处Perls染色阳性)且仅有微量铝蓄积(骨铝低于20微克/克湿重)的患者组成。B组包括15例有明显铝蓄积(钙化骨边界处铝染色阳性且骨铝为20微克/克湿重或更高)且无明显骨铁沉积(钙化骨边界处Perls染色阴性)的患者。根据类骨质体积、相对成骨细胞活性(ROBA%)以及纤维化的存在情况,将骨病分类为早期甲状旁腺功能亢进、纤维性骨炎、混合性疾病、骨软化症、动力缺乏性骨病或其他骨病情况。在A组中,12例患者中有5例表现为动力缺乏性骨病,这在未行甲状旁腺切除术的透析患者总体中是一种相当罕见的情况。事实上,在一个由80例无铁和无铝过载的患者组成的对照组中,只有5例患者表现为动力缺乏性骨病。在B组中,15例患者中有8例表现为骨软化症,15例中有2例表现为混合性疾病,这与骨铝蓄积和骨矿化缺陷发生之间已确立的关系相符。得出的结论是,透析患者的铁过载与动力缺乏性骨病的发生率增加有关。

相似文献

1
Iron overload and bone disease in chronic dialysis patients.慢性透析患者的铁过载与骨病
Nephrol Dial Transplant. 1990;5(9):781-7. doi: 10.1093/ndt/5.9.781.
2
[Aluminum and uremic bone disease. Diagnostic utility of serum aluminum and the deferoxamine (DFO) test ].[铝与尿毒症骨病。血清铝及去铁胺(DFO)试验的诊断效用]
Nefrologia. 2001 Mar-Apr;21(2):174-81.
3
The early effects of aluminium deposition and dialysis on bone in chronic renal failure: a cross-sectional bone-histomorphometric study.铝沉积和透析对慢性肾衰竭患者骨骼的早期影响:一项横断面骨组织形态计量学研究
Nephrol Dial Transplant. 1990;5(6):449-56. doi: 10.1093/ndt/5.6.449.
4
Aluminium-induced osteomalacia in severe chronic renal failure (SCRF).严重慢性肾衰竭(SCRF)中的铝诱导骨软化症。
Clin Nephrol. 1985;24 Suppl 1:S30-6.
5
Fluoride and strontium accumulation in bone does not correlate with osteoid tissue in dialysis patients.透析患者骨骼中氟化物和锶的积累与类骨质组织无关。
Nephrol Dial Transplant. 2002 Mar;17(3):449-54. doi: 10.1093/ndt/17.3.449.
6
Clinical and histologic features of iron-related bone disease in dialysis patients.
Am J Kidney Dis. 1991 May;17(5):551-61. doi: 10.1016/s0272-6386(12)80497-5.
7
High frequency of iron bone deposits in a Mexican population with renal osteodystrophy.
Nephrol Dial Transplant. 1998;13 Suppl 3:46-50. doi: 10.1093/ndt/13.suppl_3.46.
8
Bone aluminum deposition in maintenance dialysis patients treated with aluminium-free dialysate: role of aluminium hydroxide consumption.使用无铝透析液治疗的维持性透析患者的骨铝沉积:氢氧化铝摄入的作用。
Nephron. 1986;42(3):210-6. doi: 10.1159/000183669.
9
Hypercalcaemic osteomalacia due to aluminium toxicity.铝中毒所致高钙血症性骨软化症
Lancet. 1982 Nov 6;2(8306):1009-13. doi: 10.1016/s0140-6736(82)90049-6.
10
Bone aluminium in haemodialysed patients and in rats injected with aluminium chloride: relationship to impaired bone mineralisation.血液透析患者及注射氯化铝的大鼠体内的骨铝:与骨矿化受损的关系
J Clin Pathol. 1979 Aug;32(8):832-44. doi: 10.1136/jcp.32.8.832.

引用本文的文献

1
Renal osteodystrophy in a sample of patients on dialysis in Northeastern Brazil: a cross-sectional analysis.巴西东北部透析患者样本中的肾性骨营养不良:一项横断面分析。
J Bras Nefrol. 2025 Apr-Jun;47(2):e20240174. doi: 10.1590/2175-8239-JBN-2024-0174en.
2
Exploring the potential function of trace elements in human health: a therapeutic perspective.探究微量元素在人类健康中的潜在功能:治疗视角。
Mol Cell Biochem. 2023 Oct;478(10):2141-2171. doi: 10.1007/s11010-022-04638-3. Epub 2023 Jan 13.
3
The Role of Bone Biopsy in the Management of CKD-MBD.
骨活检在 CKD-MBD 管理中的作用。
Calcif Tissue Int. 2021 Apr;108(4):528-538. doi: 10.1007/s00223-021-00838-z. Epub 2021 Mar 26.
4
Next-generation phosphate binders: focus on iron-based binders.下一代磷酸盐结合剂:关注基于铁的结合剂。
Drugs. 2014 Jun;74(8):863-77. doi: 10.1007/s40265-014-0224-6.